Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RNA-directed RNA polymerase L, commonly referred to as the L protein, is a large, multifunctional enzyme that serves as the primary replicative machinery for non-segmented negative-strand RNA viruses (Mononegavirales) and several families of segmented RNA viruses, such as Bunyavirales and Arenavirales [4, 15]. It is responsible for both the replication of the viral RNA genome and the transcription of viral messenger RNAs (mRNAs) [1, 12]. The L protein is highly complex, often containing multiple domains that execute diverse enzymatic functions, including RNA-dependent RNA polymerase (RdRp) activity, mRNA capping (via guanylyltransferase and methyltransferase domains), and polyadenylation [5, 15]. In certain viruses like Hantaviruses, it also possesses an endonuclease domain used for "cap-snatching," a process where the virus steals the 5' cap from host mRNAs to initiate its own transcription [3, 4]. Because the L protein is essential for viral survival and lacks a direct functional counterpart in human cells, it is a premier target for antiviral therapy [13, 16]. Current drug candidates include nucleoside analogs that act as chain terminators and non-nucleoside inhibitors that target allosteric sites to block enzyme activity [1, 16].
Nucleoside analog-mediated chain termination, allosteric inhibition of polymerase activity, endonuclease inhibition, and methyltransferase inhibition.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA-directed RNA polymerase L (RdRp L).